Cetuximab-radiotherapy versus cetuximab-radiotherapy plus concurrent chemotherapy in patients with N0-N2a squamous cell carcinoma of the head and neck (SCCHN): Results of the GORTEC 2007-01 phase III randomized trial.

Bourhis, Jean Lausanne University Medical Center, Lausanne, Switzerland;
Sun, xu Shan Besançon Hospital, Besancon, France;
Sire, Christian CH de Bretagne Sud, Lorient, France;
Tao, Yungan Institut Gustave Roussy, Villejuif, France;
Martin, Laurent Centre Guillaume Le Conquerant, Le Havre, France;
Khoury, Cedric Centre Georges-François Leclerc, Dijon, France;
Maingon, Philippe Georges-François Leclerc Center, Radiotherapy Department, Dijon, France;
Bardet, Etienne Centre Rene Gauducheau, Nantes, France;
Lapeyre, Michel Centre Jean Perrin, Clermont, France;
Chatellier, Thierry Clinique Mutualiste, Saint Nazaire, France;
Ollivier, Nathalie Institute Gustave Roussy, Villejuif, France;
Cornely, Alexandre Institute Gustave Roussy, Villejuif, France;
Auperin, Anne Institute Gustave Roussy, Villejuif, France;